Century Therapeutics to Present at Upcoming Investor Conferences

Rhea-AI Summary

On February 1, 2023, Century Therapeutics (NASDAQ: IPSC) announced its participation in two upcoming investor conferences. The first event, The Guggenheim Healthcare Talks Oncology Day, is scheduled for February 8, 2023, at 3:55 PM ET. The second, The SVB Securities Global Biopharma Conference, will take place on February 15, 2023, at 11:20 AM ET. A replay of these events will be available on the company’s website for 30 days following the conferences. Century Therapeutics is focused on developing iPSC-derived cell therapies for cancer treatment, aiming to improve patient access and outcomes in oncology.

PHILADELPHIA, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that members of the management team will participate in the following investor conferences in February:

• The Guggenheim Healthcare Talks Oncology Day. The fireside chat will take place at 3:55 PM ET on Wednesday, February 8, 2023.
  
  
• The SVB Securities Global Biopharma Conference. The fireside chat will take place at 11:20 AM ET on Wednesday, February 15, 2023.
  

A replay of the events will be available on the “Events & Presentations” page in the “Investors” section of the Company’s website at https://investors.centurytx.com/events-and-presentations and will be available for 30 days following the events.

About Century Therapeutics

Century Therapeutics (NASDAQ: IPSC) is harnessing the power of adult stem cells to develop curative cell therapy products for cancer that we believe will allow us to overcome the limitations of first-generation cell therapies. Our genetically engineered, iPSC-derived iNK and iT cell product candidates are designed to specifically target hematologic and solid tumor cancers. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of cancer care. For more information on Century Therapeutics please visit www.centurytx.com.

Century Therapeutics Forward-Looking Statement

This press release contains forward-looking statements within the meaning of, and made pursuant to the safe harbor provisions of, The Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terms such as “may,” “might,” “will,” “should,” “expect,” “plan,” “aim,” “seek,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “forecast,” “potential” or “continue” or the negative of these terms or other similar expressions. These statements are not guarantees of future performance These risks and uncertainties are described more fully in the “Risk Factors” section of our most recent filings with the Securities and Exchange Commission and available at www.sec.gov. You should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

For More Information:
Company: Elizabeth Krutoholow – investor.relations@centurytx.com
Investors: Melissa Forst/Maghan Meyers – century@argotpartners.com
Media: Joshua R. Mansbach – century@argotpartners.com

FAQ

When will Century Therapeutics participate in the Guggenheim Healthcare Talks Oncology Day?

Century Therapeutics will participate in the Guggenheim Healthcare Talks Oncology Day on February 8, 2023, at 3:55 PM ET.

What is the date and time for Century Therapeutics at the SVB Securities Global Biopharma Conference?

Century Therapeutics will participate in the SVB Securities Global Biopharma Conference on February 15, 2023, at 11:20 AM ET.

How can I access the replays of the events featuring Century Therapeutics?

Replays of the events can be accessed on the 'Events & Presentations' page of Century Therapeutics' website for 30 days after the events.

What type of therapies does Century Therapeutics focus on developing?

Century Therapeutics focuses on developing iPSC-derived cell therapies for cancer treatment.

What does IPSC stand for in the context of Century Therapeutics?

IPSC refers to the stock symbol for Century Therapeutics, which is listed on NASDAQ.